The U.S. Food and Drug Administration approved Lenmeldy, the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic...
Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare.
X-Therma Inc., a biotechnology company...
Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...
3D printing technology has revolutionized the manufacturing process across various industries, and the field of medicine is no exception. The ability to create three-dimensional...
Prospective, Multi-Center Study Will Assess the Clinical Impact of Galleri® in addition to Currently Recommended Cancer Screenings in the Medicare Population
GRAIL, LLC, a healthcare company...
